Patents by Inventor Satoru Matayoshi

Satoru Matayoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy
    Patent number: 8053409
    Abstract: The present invention is intended to provide a novel pharmaceutical agent having an excellent preventive effect on post-stroke RSD. The present invention provides an agent for preventing the onset of post-stroke RSD, comprising natural calcitonin or a calcitonin derivative as an active ingredient. The present invention is also intended to provide a method for preventing the onset of post-stroke RSD, comprising administering natural calcitonin or a calcitonin derivative and use of natural calcitonin or a calcitonin derivative for producing an agent for preventing the onset of post-stroke RSD.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: November 8, 2011
    Assignee: Asahi Kasei Pharma Corporation
    Inventor: Satoru Matayoshi
  • AGENT FOR PROPHYLAXIS OF REFLEX SYMPATHETIC DYSTROPHY AFTER CEREBRAL APOPLEXY
    Publication number: 20110144018
    Abstract: The present invention is intended to provide a novel pharmaceutical agent having an excellent preventive effect on post-stroke RSD. The present invention provides an agent for preventing the onset of post-stroke RSD, comprising natural calcitonin or a calcitonin derivative as an active ingredient. The present invention is also intended to provide a method for preventing the onset of post-stroke RSD, comprising administering natural calcitonin or a calcitonin derivative and use of natural calcitonin or a calcitonin derivative for producing an agent for preventing the onset of post-stroke RSD.
    Type: Application
    Filed: February 18, 2011
    Publication date: June 16, 2011
    Inventor: Satoru MATAYOSHI
  • Method for prophylaxis of reflex sympathetic dystrophy after stroke
    Patent number: 7919460
    Abstract: The present invention is intended to provide a novel pharmaceutical agent having an excellent preventive effect on post-stroke RSD. The present invention provides an agent for preventing the onset of post-stroke RSD, comprising natural calcitonin or a calcitonin derivative as an active ingredient. The present invention is also intended to provide a method for preventing the onset of post-stroke RSD, comprising administering natural calcitonin or a calcitonin derivative and use of natural calcitonin or a calcitonin derivative for producing an agent for preventing the onset of post-stroke RSD.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: April 5, 2011
    Assignee: Asahi Kasei Pharma Corporation
    Inventor: Satoru Matayoshi
  • Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy
    Publication number: 20080090767
    Abstract: The present invention is intended to provide a novel pharmaceutical agent having an excellent preventive effect on post-stroke RSD. The present invention provides an agent for preventing the onset of post-stroke RSD, comprising natural calcitonin or a calcitonin derivative as an active ingredient. The present invention is also intended to provide a method for preventing the onset of post-stroke RSD, comprising administering natural calcitonin or a calcitonin derivative and use of natural calcitonin or a calcitonin derivative for producing an agent for preventing the onset of post-stroke RSD.
    Type: Application
    Filed: September 27, 2007
    Publication date: April 17, 2008
    Applicant: Asahi Kasei Pharma Corporation
    Inventor: Satoru Matayoshi